Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 4 2Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pain 3Neoplasms 2Tuberculosis 1Stomatitis 1Sarcoidosis 1Prostatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Neoplasms 1Cough 1Cancer Pain 1Agnosia 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3Standard of Care 3Oxaliplatin 3Melatonin 3Gemcitabine 3Fluorouracil 3Drug Therapy 3Ciprofloxacin 3Capecitabine 3pertuzumab 2entrectinib 2cobimetinib 2capmatinib 2atezolizumab 2alectinib 2Water 2Vemurafenib 2Trastuzumab 2Sirolimus 2Saline Solution 2Pemetrexed 2Methylphenidate 2Lidocaine 2Leucovorin 2Immunoglobulins, Intravenous 2Docetaxel 2Dexmedetomidine 2Cisplatin 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Neoplasms × Lidocaine × Clear all
NCT04741880 2021-07-30

ELSA

Instituto Nacional de Cancer, Brazil

Phase 2/3 Unknown
66 enrolled
Tumor-Agnostic

Neoplasms

NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed
33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡